PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
MKC vs. CVS
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between MKC and CVS is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

MKC vs. CVS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in McCormick & Company, Incorporated (MKC) and CVS Health Corporation (CVS). The values are adjusted to include any dividend payments, if applicable.

5,000.00%10,000.00%15,000.00%AugustSeptemberOctoberNovemberDecember2025
15,224.00%
4,031.60%
MKC
CVS

Key characteristics

Sharpe Ratio

MKC:

0.69

CVS:

-0.77

Sortino Ratio

MKC:

1.22

CVS:

-0.92

Omega Ratio

MKC:

1.14

CVS:

0.87

Calmar Ratio

MKC:

0.43

CVS:

-0.51

Martin Ratio

MKC:

2.43

CVS:

-1.21

Ulcer Index

MKC:

6.30%

CVS:

23.75%

Daily Std Dev

MKC:

22.35%

CVS:

37.27%

Max Drawdown

MKC:

-41.18%

CVS:

-64.07%

Current Drawdown

MKC:

-25.49%

CVS:

-48.06%

Fundamentals

Market Cap

MKC:

$19.75B

CVS:

$66.22B

EPS

MKC:

$2.93

CVS:

$3.94

PE Ratio

MKC:

25.02

CVS:

13.36

PEG Ratio

MKC:

2.43

CVS:

2.08

Total Revenue (TTM)

MKC:

$4.93B

CVS:

$275.10B

Gross Profit (TTM)

MKC:

$1.87B

CVS:

$38.50B

EBITDA (TTM)

MKC:

$940.10M

CVS:

$9.67B

Returns By Period

In the year-to-date period, MKC achieves a -3.84% return, which is significantly lower than CVS's 17.22% return. Over the past 10 years, MKC has outperformed CVS with an annualized return of 8.81%, while CVS has yielded a comparatively lower -3.64% annualized return.


MKC

YTD

-3.84%

1M

-6.86%

6M

0.73%

1Y

15.50%

5Y*

-0.96%

10Y*

8.81%

CVS

YTD

17.22%

1M

20.19%

6M

-9.67%

1Y

-25.80%

5Y*

-4.25%

10Y*

-3.64%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

MKC vs. CVS — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MKC
The Risk-Adjusted Performance Rank of MKC is 6666
Overall Rank
The Sharpe Ratio Rank of MKC is 7070
Sharpe Ratio Rank
The Sortino Ratio Rank of MKC is 6565
Sortino Ratio Rank
The Omega Ratio Rank of MKC is 6161
Omega Ratio Rank
The Calmar Ratio Rank of MKC is 6565
Calmar Ratio Rank
The Martin Ratio Rank of MKC is 7070
Martin Ratio Rank

CVS
The Risk-Adjusted Performance Rank of CVS is 1212
Overall Rank
The Sharpe Ratio Rank of CVS is 99
Sharpe Ratio Rank
The Sortino Ratio Rank of CVS is 1212
Sortino Ratio Rank
The Omega Ratio Rank of CVS is 1111
Omega Ratio Rank
The Calmar Ratio Rank of CVS is 1616
Calmar Ratio Rank
The Martin Ratio Rank of CVS is 1515
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

MKC vs. CVS - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for McCormick & Company, Incorporated (MKC) and CVS Health Corporation (CVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for MKC, currently valued at 0.69, compared to the broader market-2.000.002.004.000.69-0.77
The chart of Sortino ratio for MKC, currently valued at 1.22, compared to the broader market-4.00-2.000.002.004.001.22-0.92
The chart of Omega ratio for MKC, currently valued at 1.14, compared to the broader market0.501.001.502.001.140.87
The chart of Calmar ratio for MKC, currently valued at 0.43, compared to the broader market0.002.004.006.000.43-0.51
The chart of Martin ratio for MKC, currently valued at 2.43, compared to the broader market-10.000.0010.0020.0030.002.43-1.21
MKC
CVS

The current MKC Sharpe Ratio is 0.69, which is higher than the CVS Sharpe Ratio of -0.77. The chart below compares the historical Sharpe Ratios of MKC and CVS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.50AugustSeptemberOctoberNovemberDecember2025
0.69
-0.77
MKC
CVS

Dividends

MKC vs. CVS - Dividend Comparison

MKC's dividend yield for the trailing twelve months is around 2.33%, less than CVS's 3.79% yield.


TTM20242023202220212020201920182017201620152014
MKC
McCormick & Company, Incorporated
2.33%2.24%2.32%1.81%1.44%1.15%1.37%1.53%1.89%1.89%1.91%2.03%
CVS
CVS Health Corporation
3.79%5.93%3.06%2.36%1.94%2.93%2.69%3.05%2.76%2.15%1.43%1.14%

Drawdowns

MKC vs. CVS - Drawdown Comparison

The maximum MKC drawdown since its inception was -41.18%, smaller than the maximum CVS drawdown of -64.07%. Use the drawdown chart below to compare losses from any high point for MKC and CVS. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%AugustSeptemberOctoberNovemberDecember2025
-25.49%
-48.06%
MKC
CVS

Volatility

MKC vs. CVS - Volatility Comparison

The current volatility for McCormick & Company, Incorporated (MKC) is 6.28%, while CVS Health Corporation (CVS) has a volatility of 12.15%. This indicates that MKC experiences smaller price fluctuations and is considered to be less risky than CVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%14.00%16.00%AugustSeptemberOctoberNovemberDecember2025
6.28%
12.15%
MKC
CVS

Financials

MKC vs. CVS - Financials Comparison

This section allows you to compare key financial metrics between McCormick & Company, Incorporated and CVS Health Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab